На главную
Результаты поиска “Anti retro viral resistance testing”
HIV Resistance: Basics principles Part 1/3
 
08:02
Dr. Catherine Orrell of the Desmond Tutu HIV Foundation discusses the Basics of Anti-retroviral Resistance in HIV. This part 1 of a 3 part series. Your feedback is appreciated.
Просмотров: 7845 Aviro
Basic Course in HIV - HIV Resistance and Antiretroviral Therapy | Center for AIDS Research
 
01:05:11
In conjunction with Brian Zanoni of Harvard Medical School the Harvard University CFAR presents BASIC Course in HIV. BASIC Course in HIV is a basic but comprehensive course on HIV. Please allow 5 seconds for each video to begin playing.
Просмотров: 5383 Harvard University
HIV Resistance: Genotyping, Archiving and Salvage therapy Part 3/3
 
06:54
Dr Catherine Orrell of Desmond Tutu HIV discusses the correct application and interpretation of HIV genotyping tests and the process of choosing a salvage regimen.
Просмотров: 2813 Aviro
Introduction to HIV Resistance Testing
 
14:14
David Spach, MD - Find this and other presentations at http://depts.washington.edu/nwaetc/presentations/?PID=46
Просмотров: 2627 MWAETC: Project ECHO
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
 
19:57
An Open Access Protocol from JoVE - Medicine. http://www.jove.com/video/51242/an-affordable-hiv-1-drug-resistance-monitoring-method-for-resource Drug resistance testing for HIV-1 infected individuals failing antiretroviral therapy (ART) can guide future therapies and improve treatment outcomes. Optimizing individual and population health outcomes in high HIV prevalence but resource-limited settings will ultimately require affordable and accessible drug resistance genotyping and interpretation methods. To view more Medicine video protocols, visit http://www.jove.com/.
Просмотров: 270 JoVE (Journal of Visualized Experiments)
HIV Strains Developing Resistance to Medication
 
04:25
HIV strains are becoming resistant to a key antiretroviral drug called Tenofovir, which is commonly used to prevent and fight the virus, according to research led by University College London. The study, which covered a 17-year period, looked at 1,920 HIV patients worldwide who had treatment failure and found that HIV was resistant to Tenofovir in 60% of selected cases in Africa. What’s behind the spread of HIV-drug resistance? We look at the concerning results on the Lip News with Jo Ankier and Margaret Howell. http://www.bbc.com/news/health-35433856 Newest Lip News playlist: https://www.youtube.com/watch?v=W9qtAnlxyiQ&index=1&list=PLjk3H0GXhhGcjJDo6cQBCQprDMQyUQY3r CRIME TIME clips playlist – https://www.youtube.com/watch?v=_X2DJUk8ctw&list=PLjk3H0GXhhGeC9DbpSnIvd2i9BHh2dBvv&index=1 BYOD (Bring Your Own Doc) Highlight Videos- https://www.youtube.com/watch?v=NeVzXmMOpWQ&index=1&list=PLjk3H0GXhhGeu2DCf6Ouo7hTsA5QB2MAL MEDIA MAYHEM short videos playlist - https://www.youtube.com/watch?v=B7ZlaiaUaz8&index=1&list=PLjk3H0GXhhGcz4un-zws5sMlCLk3NNjDP http://www.thelip.tv https://www.facebook.com/thelip.tv http://www.youtube.com/theliptv
Просмотров: 3397 TheLipTV2
Treating HIV: Antiretroviral drugs | Infectious diseases | NCLEX-RN | Khan Academy
 
10:31
Visit us (http://www.khanacademy.org/science/healthcare-and-medicine) for health and medicine content or (http://www.khanacademy.org/test-prep/mcat) for MCAT related content. These videos do not provide medical advice and are for informational purposes only. The videos are not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen in any Khan Academy video. Created by Vishal Punwani. Watch the next lesson: https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/rn-hiv-and-aids/v/haart-treatment-for-hiv-who-what-why-when-and-how?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn Missed the previous lesson? https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/rn-hiv-and-aids/v/diagnosing-hiv-concepts-and-tests?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn NCLEX-RN on Khan Academy: A collection of questions from content covered on the NCLEX-RN. These questions are available under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 United States License (available at http://creativecommons.org/licenses/by-nc-sa/3.0/us/). About Khan Academy: Khan Academy offers practice exercises, instructional videos, and a personalized learning dashboard that empower learners to study at their own pace in and outside of the classroom. We tackle math, science, computer programming, history, art history, economics, and more. Our math missions guide learners from kindergarten to calculus using state-of-the-art, adaptive technology that identifies strengths and learning gaps. We've also partnered with institutions like NASA, The Museum of Modern Art, The California Academy of Sciences, and MIT to offer specialized content. For free. For everyone. Forever. #YouCanLearnAnything Subscribe to Khan Academy’s NCLEX-RN channel: https://www.youtube.com/channel/UCDx5cTeADCvKWgF9x_Qjz3g?sub_confirmation=1 Subscribe to Khan Academy: https://www.youtube.com/subscription_center?add_user=khanacademy
Просмотров: 208326 khanacademymedicine
HIV: Avoiding Resistance
 
02:39
HIV can mutate. It can change. And it can become resistant to treatment. But that doesn’t have to happen. Find out what causes resistance and what you can do to help stop it.
Просмотров: 53234 Help Stop the Virus
Patients should start HIV drugs as early as possible, study finds
 
05:55
Federal health officials now say that individuals with HIV should start antiretroviral drugs as soon as they are diagnosed. That announcement was made after a large clinical trial was stopped because the evidence was so overwhelming. But how do you get those drugs to patients who need them around the world? Dr. Anthony Fauci of the National Institutes of Health joins Judy Woodruff to discuss. Read the transcript: http://www.pbs.org/newshour/bb/patients-start-hiv-drugs-early-possible-study-finds/#transcript
Просмотров: 4417 PBS NewsHour
WHO: Action against HIV drug resistance threat
 
04:12
The World Health Organization launches a new landmark report showing high levels of resistance to HIV drugs in some countries which could undermine global progress in the response to HIV. The Organization issues new guidelines that advise countries take timely action to respond to drug resistance and prevent its emergence. WHO also calls for joint global action with a new five-year plan. More information: http://www.who.int/hiv/topics/drugresistance/en/
Просмотров: 7340 World Health Organization
Adherence and Resistance Issues with HIV Drug Treatment
 
03:11
For people living with HIV, there can be a lot of different reasons why taking medication on a regular basis can be difficult, but two major factors affecting the success of treatment are adherence and resistance. This animation describes how adhering to your prescribed medication schedule is beneficial and minimizes the risk that your HIV will develop resistance to your medical treatment. It is important for people living with HIV to listen to their doctor and to take their HIV medicines on a regular basis, as prescribed. To learn more visit http://www.AnimatedHIVScience.com
Просмотров: 14320 Animated HIV Science
[A030] Convenient drug-resistance testing of HIV mutants
 
18:45
Video presentation for: Zhu, Q.; Kai, M. Convenient drug-resistance testing of HIV mutants. In Proceedings of the 1st Int. Electron. Conf. Med. Chem., 2–27 November 2015; Sciforum Electronic Conference Series, Vol. 1, 2015, A030; doi:10.3390/ecmc-1-A030
Просмотров: 147 MDPI Sciforum
Seminar: New HIV GT Assay based on NGS for HIV Drug Resistance Testing
 
16:55
Dr Rolf Kaiser Uniklinik Köln
Просмотров: 254 Vela Diagnostics (HQ)
New Antiretroviral Agents, and HIV Drug Resistance
 
23:08
Second Annual Update on HIV AIDS and Hepatitis C Infection Program MD Anderson Cancer Center Video New Antiretroviral Agents, and HIV Drug Resistance
Просмотров: 1406 Worldwide Institue for Medical Education
Understanding HIV Treatment
 
03:28
There have been many advances on the HIV medication front since the days when "monotherapy" (such as AZT) was the standard protocol for treating the disease. Today, several medications are often conviently combined into one pill - known as "combination therapy" or "Highly Active Antiretroviral Therapy (HAART) - which greatly increases the likelihood that patients will adhere to their treatment regimens. Patients can also choose from many different classes of medications to find the drug (or drugs) that best fit their lifestyle and have few, if any, side effects.
Просмотров: 29751 UB2 Inc
HIV Resistance
 
05:23
a detailed 3d animation about hiv resistance in organism Please note that this video is not my copyrighted material.I am just sharing my collection from internet.So the credit goes to the real copyright owners. visit my website for more medical animations and their downloads: http://3dmed.wetpaint.com/
Просмотров: 46099 Rufus Rajadurai
HIV: Mechanisms of NNRTI Resistance
 
01:06
This animation describes how mutations acquired by the HIV reverse transcriptase enzyme can effectively prevent NNRTI medicines from being able to bind to it. Narrated by Dr. Mark Wainberg, Professor of Medicine and of Microbiology at McGill University, Montreal, Quebec, a Canadian AIDS researcher and activist. For more information please visit http://www.AnimatedHIVScience.com
Просмотров: 3002 Mechanisms in Medicine
Aldatu Biosciences explain how they're helping overcome HIV drug resistance
 
05:12
Aldatu Biosciences has developed a new genotype test that helps ensure HIV patients are receiving the correct antiretroviral medication. In 2014 they won the Bertarelli Prize at Harvard University's Innovation Lab, which is helping them to commercialise their technology and provide drug resistance testing to HIV patients.
Просмотров: 689 Bertarelli Foundation
Thai Government Plans to Screen for HIV Drug Resistance
 
03:02
Many HIV-infected patients have adverse reactions to anti-retroviral drugs, and others fail to take the drugs properly, which means resistance to the drugs may increase. In Thailand, the government plans to provide free DNA testing to screen for adverse reactions, to help reduce the threat of resistance.
Просмотров: 1509 VOA News
Transmitted Drug Resistance in HIV
 
01:57
This is a short movie about transmitted drug resistance. It explains some people get infected with a virus strain that is resistant to certain kinds of drugs. To make sure that everyone gets the right treatment, someone's virus can be sequenced in a laboratory to check whether it has resistance mutations and to choose the right treatment based on the results. Unfortunately, this is not possible in many poor countries. If you are interested in learning more about drug resistance, have a look at my review paper here: http://www.pagepress.org/journals/index.php/idr/article/view/idr.2013.s1.e5
Просмотров: 593 Pleuni Pennings
HIV Resistance Part 1
 
09:50
We explore the subject of HIV that is resistant to anti-HIV medications. This is for Frontline TEACH. For more info, please go to http://www.aidslibrary.org/.
Просмотров: 2380 aidslibrary
HIV, AIDS, and ARVs: Take Your Antiretrovirals as Prescribed!
 
10:14
Becky Kuhn, M.D., explains why it's so important for HIV positive people who are on antiretroviral medications (ARVs) to take their medications at the prescribed dosages on the prescribed schedules. This will reduce the risk of developing a strain of HIV that is resistant to the ARV medication. This video is freely downloadable from http://www.archive.org/details/aidsvideos_adherence . Visit http://www.GlobalLifeworks.org and http://AIDSvideos.org to learn more. Disabled accessibility: The transcript for this and many other AIDSvideos.org videos can be downloaded from http://aidsvideos.org/translate.shtml .[Do you want to help prevent the spread of HIV/AIDS? Are you fluent in a language other than English? Then volunteer to translate our videos into other languages! Click http://AIDSvideos.org/translate.shtml to to learn how you can help!!! © Copyright 2007-2011 Global Lifeworks. All rights reserved. This work is licensed to be used for non-commercial purposes under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/.]
Просмотров: 12125 AIDSvideos
HAART treatment for HIV - Who, what, why, when, and how | NCLEX-RN | Khan Academy
 
08:37
Visit us (http://www.khanacademy.org/science/healthcare-and-medicine) for health and medicine content or (http://www.khanacademy.org/test-prep/mcat) for MCAT related content. These videos do not provide medical advice and are for informational purposes only. The videos are not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen in any Khan Academy video. Created by Vishal Punwani. Watch the next lesson: https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/rn-hiv-and-aids/v/defining-aids-and-aids-defining-illnesses-bumper?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn Missed the previous lesson? https://www.khanacademy.org/test-prep/nclex-rn/rn-infectious-diseases/rn-hiv-and-aids/v/treating-hiv-antiretroviral-drugs?utm_source=YT&utm_medium=Desc&utm_campaign=Nclex-rn NCLEX-RN on Khan Academy: A collection of questions from content covered on the NCLEX-RN. These questions are available under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 United States License (available at http://creativecommons.org/licenses/by-nc-sa/3.0/us/). About Khan Academy: Khan Academy offers practice exercises, instructional videos, and a personalized learning dashboard that empower learners to study at their own pace in and outside of the classroom. We tackle math, science, computer programming, history, art history, economics, and more. Our math missions guide learners from kindergarten to calculus using state-of-the-art, adaptive technology that identifies strengths and learning gaps. We've also partnered with institutions like NASA, The Museum of Modern Art, The California Academy of Sciences, and MIT to offer specialized content. For free. For everyone. Forever. #YouCanLearnAnything Subscribe to Khan Academy’s NCLEX-RN channel: https://www.youtube.com/channel/UCDx5cTeADCvKWgF9x_Qjz3g?sub_confirmation=1 Subscribe to Khan Academy: https://www.youtube.com/subscription_center?add_user=khanacademy
Просмотров: 86953 khanacademymedicine
Tanzania Clinic & Cepheid GeneXpert HIV Testing
 
06:29
An incredible story of a study in rapid HIV testing on mothers and babies in Rural Tanzania.
Просмотров: 650 CepheidNews
Student Helps New HIV Technology Reach Patients
 
00:58
For 1 in 10 people treated for HIV, the virus is resistant to the go-to antiretroviral drugs. And for cash-strapped health systems around the world, drug-resistance testing is too expensive. But Aldatu Biosciences is changing that, says MPH student Brad Padilla, who completed his practicum at the Cambridge-based startup this summer. “Their technology is helping to overcome what were assumed to be barriers in drug resistance testing,” Padilla says. Instead of standard DNA and RNA sequencing, Aldatu’s test only looks at the six specific parts of the HIV genome where the relevant mutations would be. That makes for a much cheaper test, and potentially for cost-effective testing of everyone entering treatment. “It’s a technology that could change a lot of people’s lives,” Padilla says. Because the technology is so new, a lot has to happen for it to go into widespread use—which is where Padilla comes in. For the first half of his practicum, Padilla researched the regulatory pathways Aldatu’s test would need to go through to start being used throughout Sub-Saharan Africa.
Просмотров: 172 BU School of Public Health
Antiretroviral Therapy (ART) & HIV Explained : Pharmamates
 
05:51
The management of HIV/AIDS normally includes the use of multiple antiretroviral drugs in an attempt to control HIV infection. There are several classes of antiretroviral agents that act on different stages of the HIV life-cycle. The use of multiple drugs that act on different viral targets is known as highly active antiretroviral therapy (HAART). HAART decreases the patient's total burden of HIV, maintains function of the immune system, and prevents opportunistic infections that often lead to death.
Просмотров: 8300 Pharmamates
Antiretroviral Therapy
 
01:21:27
Antiretroviral therapy (ART) is the use of HIV medicines to treat infection. ART is recommended for everyone infected with HIV, not only for their own health, but also to reduce the risk of transmission to others. This video provides an introduction to the use of antiretroviral medications.
Просмотров: 1256 Michigan HHS
Brief Overview of ART Resistance
 
30:33
Antiretroviral drugs, ARV, ART, Resistance
Просмотров: 374 Southeast AETC
Acute Side Effects from Antiretroviral Medication
 
30:17
David Hachey, Pharm.D., BCPS, AAHIVP - Find this and other presentations at http://depts.washington.edu/nwaetc/presentations/?PID=25
Просмотров: 9254 MWAETC: Project ECHO
Use of Antiretroviral Drugs for Prevention of New Infections with HIV
 
01:04:08
- By: David van de Vijver, Erasmus Medical Center, Rotterdam, Netherlands - Date: 2012-02-07 15:00:00 - Description: Every year 2.5 million individuals become newly infected with HIV. This highlights that current ways for prevention of transmission, such as use of condoms, are not sufficient to limit the spread of HIV infection. Novel prevention strategies using antiretroviral drugs are being developed. One of these strategies is pre-exposure prophylaxis (PrEP) with antiretroviral drugs. The effect of drug resistance will be a critical issue in the use of PrEP. Drug resistance will reduce the effectiveness of PrEP. This detrimental effect could be counterbalanced by the reduced fitness of drug-resistant HIV, which may result in lower levels of virus particles. Because the amount of virus is a major determinant of the risk of transmission, drug-resistant HIV could be transmitted less easily. During the seminar I will discuss that the benefits of PrEP are expected to outweigh the risks associated with drug resistance (1.2). Another prevention strategy is test and treat in which testing positive for HIV is followed by treatment. HIV-testing can prevent new infections as individuals aware of their HIV-status can reduce their risk behaviour. Treatment of infected individuals can prevent new infections, as antiretroviral drugs can suppress the amount of virus to undetectable levels. Mathematical modelling has predicted that universal HIV testing followed by immediate start of antiretroviral drugs for those individuals who test positive, could reduce the HIV pandemic to one incident case of HIV per 1000 people within a decade (3). But, universal testing and immediate treatment may not be achieved in clinical practice in Africa (4) where most new infections occur World-wide. We used realistic data from a rural hospital in Macha in Zambia and used assumptions about testing and treatment that can be achieved in clinical practice. Using mathematical modelling we found that test and treat can strongly reduce the incidence of HIV but cannot eliminate the epidemic. Test and treat will lead to an increased prevalence of HIV as infected individuals will live longer.
Antiretroviral Therapy Guidelines
 
15:13
Christian B. Ramers, MD, MPH - Find this and other presentations at http://depts.washington.edu/nwaetc/presentations/?PID=16
Просмотров: 4773 MWAETC: Project ECHO
HIV Patients Found To Be Resistant to Old & New Drugs
 
00:57
On Thursday, researchers report, that a significant number of people with HIV have strains of the AIDS-causing virus that are resistant to both older and newer drugs. Researchers looked at 712 HIV patients worldwide, whose infection was not controlled by antiretroviral drugs. They found that 16 percent of the patients whose infection was resistant to modern drugs, had HIV mutations linked with resistance to older drugs called thymidine analogues. Study lead author Ravi Gupta, of University College London, said, "We were very surprised to see that so many people were resistant to both drugs, as we didn't think this was possible." Gupta said that they would require easy-to-use resistance-testing kits to help screen for drug resistance before giving people treatment. As this would also help doctors to "monitor HIV drug resistance globally more effectively." http://www.upi.com/Health_News/2016/12/01/Many-HIV-patients-found-to-be-resistant-to-old-and-new-drugs/9951480618845/ http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Просмотров: 230 Wochit News
Compliance Challenges in Antiretroviral (ARV) Therapy
 
08:48
Phil Johnson, M.D. discusses why it's so important for HIV/AIDS patients to follow their antiretroviral (ARV) medication regimen as prescribed. During active infection, up to 10 billion HIV particles will be created each day. This provides ample chance for the virus to mutate in ways that provide resistance to the medication. By keeping the blood levels of the ARV medication high, that will keep the viral load low and reduce the opportunity for resistance mutations to flourish. When HIV develops resistance to one medication, it may develop resistance to other ones at the same time. Patients may also have to deal with side effects such as the redistribution of fat in the body and increases to their cholesterol level. Not every patient can tolerate every ARV. Therefore, it's critical for patients to make every ARV last as long as possible. When people with resistant HIV have unprotected sex, they may transmit resistant HIV to their sex partners, meaning the newly infected person will have far fewer treatment options. Genetic testing of the virus can be used to determine which medications the patient's particular strain(s) will be resistant to. This video is freely downloadable from http://www.archive.org/details/aidsvideos_arv_challenges . Visit http://www.GlobalLifeworks.org and http://AIDSvideos.org to learn more. [Do you want to help prevent the spread of HIV/AIDS? Are you fluent in a language other than English? Then volunteer to translate our videos into other languages! Click http://AIDSvideos.org/translate.shtml to to learn how you can help!!! © Copyright 2007-2011 Global Lifeworks. All rights reserved. This work is licensed to be used for non-commercial purposes under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/.]
Просмотров: 4127 AIDSvideos
3  HIV   Benefits of early treatment with antiretroviral therapy
 
05:11
NSW HIV Support Program Video Series Every person diagnosed with HIV has the right to and should be offered 5 Key Support Services: Effective clinical management, including access to treatment Psychosocial support Counselling about prevention of transmission of HIV to others, including the role of treatment in reducing the risk of transmission Support to ensure that all at risk partners are identified and tested for HIV Linkage to relevant specialist, community and peer support services The NSW HIV Support Program ensures that expert advice, support and resources needed by doctors to deliver the 5 Key Support Services are available at the time of making an HIV diagnosis. These short videos have been developed through sector-wide consultation and are part of a resource package for health professionals and people living with HIV across NSW. web: http://www.health.nsw.gov.au/endinghiv/Pages/video-series.aspx
Просмотров: 2405 NSW Health
Testing for HIV treatment success
 
03:06
Only 4 out of 10 of people living with HIV on antiretroviral therapy have access to viral load tests, a key marker of treatment success. Here is how Unitaid is changing that in partnership with Solthis. Unitaid is supporting the OPP-era project implemented by Solthis, ANRS, expertise France and Sidaction in Burundi, Cameroon, Cote d’Ivoire and Guinea to improve care and treatment for people living with HIV through better access to HIV viral load testing. Click on the CC button (bottom right corner) to see subtitles in English.
Просмотров: 273 Unitaid
#PMLive: DRUG RESISTANT HIV
 
03:07
If you are newly infected with HIV and you’re failing to respond to the Anti RetroViral drugs, you could have acquired drug resistant HIV from your partner. Dr. Noah Kiwanuka from the School of Public Health warns that all newly infected people that do not respond to the 1st line treatment of ARVs acquired the deadly type of HIV that does not respond to ARVs. Here are the details.
Просмотров: 62 Urban TV Uganda
Animation of an HI-Virus and the Antiretroviral Methode
 
03:55
Its an simply make animation about the HI-Virus and the antiretroviral methode . have fun with
Просмотров: 7874 MannAusPeru
Importance of taking antiretroviral medication correctly
 
05:28
AMS' Dr. Elizabeth Kihika discusses the importance of taking Antiretroviral medication correctly, which most importantly helps prevent the virus from developing resistance against the medication. Watch to find out more...
Просмотров: 85 Alive Medical Services Uganda
Developing Antiretroviral Therapy in Africa (DART Clinical Trial) -- Policy Recommendations
 
10:01
Leading HIV investigators from the UK and Africa have demonstrated that many more people living with HIV in sub-Saharan Africa could be treated if laboratory tests were used in a targeted rather than routine way. In this short film, trial participants, practitioners and investigators connected to the trial explain how maintaining and scaling-up access to Antiretroviral Therapy (ART) in low- and middle-income countries could be possible on current funding levels, even in the midst of a global economic crisis.
Просмотров: 1984 Medical Research Council
Antiretroviral Drugs: The Science of Panic
 
01:19:51
A documentary by Isabel Otaduy Sömme and Patrizia Monzani with Arantxa Martinez http://www.lacienciadelpanico.tk/ ¿Sabías que muchos seropositivos viven bien y sanos durante muchos años sin tomar ningún medicamento? Hemos descubierto muchas otras cosas que tú probablemente no sabes. In this newly-released documenary Laciencia del Panico (2011), filmmakers Isabel Otaduy Sömme and Patrizia Monzani allow allegedly "HIV-positive" (seropositive) people to explain -- in their own words -- why they refuse to take the deadly AZT & Antiretroviral Drugs and why they attribute their health to their refusal to take the toxic drugs: "I've had a positive diagnosis for 16 years now. Two years ago, I discovered the truth about this horrifying scam. And after 7 years of taking life-threateing drugs, I threw all of the ARV's in the trash. And I never looked back." (former AID$ patient) The film explains why clinics and health ministries around the world falsely report AID$ cases for political reasons: "In early 2000 I was invited to a conference in India... They told us about a dispensary in the city of Nagpur where they treated AID$ patients: all men, all suffering end-stage tuberculosis who weighed 40 kilos (90 pounds) at most. It was a tragic sight. And because they were all seropositive, they wanted to give them AZT. "That same afternoon, we were escorted to Delhi for a reception put on by the Indian Ministry of Health. There I had the chance to talk with the second-in-command at the Ministry of Health. I told him about our visit to the dispensary and expressed how shocked I was. And he told me, "Doctor, I understand, but you have to understand us too: If we told the World Health Organization in Geneva that there were 10,000 cases of tuberculosis in Nagpur, they'll tell us that's nothing new.. But if we tell them there are 10,000 cases of AIDS, they'll send us millions of dollars." (1:00:47 -- Etienne de Harven, MD, Professor Emeritus (Pathology), University of Toronto, Ontario, Canada.) http://www.omsj.org/corruption/new-film-the-science-of-panic The deliberate false Information that HIV/AID$ Denialists from the U.S. Center for Disease Control, Dr Becky Kuhn and her arrogant camera man Eric Krock AID$Videos, Wikipedia famed Scientist Joe Mark Lawson a.k.a. C0nc0rdance, avid atheist,demigod guru xxxThePeachxxx and many other denialists on youtube who promote the fraudulent "HIV" test Kit campaigns and many other scientific myths surrounding Dr Robert C. Gallo's scientific misconduct, International lawsuit with French scientists and his false HIV theories of AID$. Please do your homework and decide for yourself against these political juggernauts of AID$ Beliefism and Gallo Denialism on youtube and elsewhere on the internet. HIV Test Kits are a potential for Iatrogenic harm and death. Mass Genocide.
Просмотров: 5622 AIDSTruth
HIV Resistance Part 2
 
08:00
We explore the subject of HIV that is resistant to anti-HIV medications. This is for Frontline TEACH. For more info, please go to http://www.aidslibrary.org/.
Просмотров: 1082 aidslibrary
Understanding HIV Infection and HIV Resistance - Jamie Morano, MD
 
19:27
Dr. Jamie Morano reviews HIV infection. She starts out by presenting up to date statistics about the current epidemiology of HIV infection across the US and Florida. She then goes on to discuss the HIV life cycle, and how various antiretroviral treatments appear to interact with the virus at different points of the viral reproductive process. HIV resistance mechanisms are also addressed. Lastly, she shares her recommendations on strategies useful to selecting an ideal antiretroviral regimen for an HIV positive patient.
Просмотров: 107 IDPodcasts
Justen Manasa's PhD Thesis on HIV-1 Drug Resistance in Africa - a summary
 
06:57
This is a video that summarizes Justen Manasa PhD thesis at University of KwaZulu-Natal. In this video Justen will describe his 5 first author peer-reviewed publications arising form this thesis and also its impact on the reduction of price of HIV drug resistance testing in Africa. Well done Justen for a great PhD and for innovative work on the laboratory and in front of cameras. All of Justen's publications are openly accessible at: http://bioafrica.net/people.php?peopleid=3
Просмотров: 494 krisp
Recreational Drugs, HIV, and Antiretroviral Therapy
 
52:09
This webinar discusses commonly used recreational drugs and the complications found with patients living with HIV. It was filmed in November 2011 by Frank Romanelli, PharmD, MPH, BCPS. For more information, please visit http://www.seatec.emory.edu/training_programs/on_demand_programs.html.
Просмотров: 3726 Emory University
Using technology to improve HIV antiretroviral adherence  by Jessica Haberer, M.D.
 
59:03
Jessica Haberer, M.D. Center for Global Health Massachusetts General Hospital and Harvard University ■ Jessica Haberer received her medical degree from Yale University and a master's degree in Health Services Research from Stanford University. She completed an internship and residency in Internal Medicine at the University of California, San Francisco. ■ After finishing her training, she worked for the William J. Clinton Foundation HIV/AIDS Initiative in Beijing, China, where she served as a Clinical and Research Advisor to the Chinese National Center for AIDS. ■ Dr. Haberer developed in interest in adherence to ART while in China and began studying multiple measures of ART adherence among children and adults in developing settings. She joined the faculty at the UCSF in 2007 and was recruited to Massachusetts General Hospital Center for Global Health and Harvard Medical School Department of Medicine in 2008. ■ Her work focuses on the study of real-time adherence monitoring and intervention strategies for ART and pre-exposure prophylaxis against HIV infection. Her current projects are based in Uganda, Kenya, and South Africa.
Просмотров: 290 HIV Center NYC
HIV Drug resistance
 
03:53
When the AIDS virus, HIV, starts resisting the drugs that try to kill it and give the patient more years to live, then there is a massive problem. In a research carried out in three districts, Kampla, Fortportal and Mbale by Pharm Access Foundation from Netherlands and Uganda's Joint clinical Research Centre, it has been discovered that one in every eight people in the three districts has HIV drug resistance. Drug stock outs and patients' laziness in taking their drugs, have been highlighted as the main cause.
Просмотров: 601 NTVUganda
HIV Resistance Part 3
 
10:03
We explore the subject of HIV that is resistant to anti-HIV medications. This is for Frontline TEACH. For more info, please go to http://www.aidslibrary.org/.
Просмотров: 861 aidslibrary
ANTIRETROVIRAL DRUGS  SIMPLIFIED / MNEMONIC SERIES #4
 
01:40
ANTIRETROVIRAL DRUGS SIMPLIFIED / MNEMONIC SERIES #4
Просмотров: 50777 Medinaz